Literature DB >> 32428528

Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis.

Benjamin Ungar1, Ana B Pavel1, Randall Li1, Grace Kimmel1, John Nia1, Peter Hashim1, Hee Jin Kim1, Margot Chima1, Anjali S Vekaria1, Yeriel Estrada1, Hui Xu1, Xiangyu Peng1, Giselle K Singer1, Danielle Baum1, Yasaman Mansouri1, Mark Taliercio1, Emma Guttman-Yassky2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32428528     DOI： 10.1016/j.jaci.2020.04.055

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  15 in total

Review 1.  New Topical Therapies in Development for Atopic Dermatitis.

Authors:  Egídio Freitas; Melinda Gooderham; Tiago Torres
Journal:  Drugs       Date:  2022-05-21       Impact factor: 9.546

2.  Cutaneous Transcriptomics Identifies Fibroproliferative and Neurovascular Gene Dysregulation in Prurigo Nodularis Compared with Psoriasis and Atopic Dermatitis.

Authors:  Nishadh Sutaria; Martin Prince Alphonse; Youkyung S Roh; Justin Choi; Varsha Parthasarathy; Junwen Deng; Zachary A Bordeaux; Matthew T Taylor; Thomas Pritchard; Noori Kim; Crystal Aguh; Yevgeniy R Semenov; Nathan K Archer; Luis A Garza; Sewon Kang; Shawn G Kwatra
Journal:  J Invest Dermatol       Date:  2022-03-04       Impact factor: 7.590

Review 3.  Atopic dermatitis: an expanding therapeutic pipeline for a complex disease.

Authors:  Thomas Bieber
Journal:  Nat Rev Drug Discov       Date:  2021-08-20       Impact factor: 84.694

Review 4.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

Review 5.  Novel Targeted Biological Agents for the Treatment of Atopic Dermatitis.

Authors:  Nan Yang; Zeyu Chen; Xilin Zhang; Yuling Shi
Journal:  BioDrugs       Date:  2021-07-02       Impact factor: 5.807

Review 6.  Which Way Do We Go? Complex Interactions in Atopic Dermatitis Pathogenesis.

Authors:  Garrett J Patrick; Nathan K Archer; Lloyd S Miller
Journal:  J Invest Dermatol       Date:  2020-09-15       Impact factor: 8.551

Review 7.  Candida albicans and candidalysin in inflammatory disorders and cancer.

Authors:  Jemima Ho; Giorgio Camilli; James S Griffiths; Jonathan P Richardson; Nessim Kichik; Julian R Naglik
Journal:  Immunology       Date:  2020-09-13       Impact factor: 7.397

Review 8.  The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside.

Authors:  Taoming Liu; Sheng Li; Shuni Ying; Shunli Tang; Yuwei Ding; Yali Li; Jianjun Qiao; Hong Fang
Journal:  Front Immunol       Date:  2020-11-17       Impact factor: 7.561

9.  Cytokine RNA In Situ Hybridization Permits Individualized Molecular Phenotyping in Biopsies of Psoriasis and Atopic Dermatitis.

Authors:  Alice Wang; Alexander L Fogel; Michael J Murphy; Gauri Panse; Meaghan K McGeary; Jennifer M McNiff; Marcus Bosenberg; Matthew D Vesely; Jeffrey M Cohen; Christine J Ko; Brett A King; William Damsky
Journal:  JID Innov       Date:  2021-05-07

10.  Interferon-γ downregulates tight junction function, which is rescued by interleukin-17A.

Authors:  Yukiko Mizutani; Nao Takagi; Haruna Nagata; Shintaro Inoue
Journal:  Exp Dermatol       Date:  2021-07-10       Impact factor: 4.511
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.